Clinical Director Dr Robert Weinkove says ‘site activation’ in Christchurch and Auckland marks a significant milestone for the clinical trial, and means more patients can be treated, closer to home.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback